Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes

Diabetologia

Volumn 54, Issue 4, 2011, Pages 979-988

  Saleh, M A ^a   Boesen, E I ^a   Pollock, J S ^a   Savin, V J ^b   Pollock, D M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Albuminuria; Diabetic nephropathy; Endothelin 1; Glomerular permeability; MCP 1; Nephrin; Palb; sICAM 1

Indexed keywords

ALBUMIN; ATRASENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR A; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; NEPHRIN; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULAR DYSFUNCTION; GLOMERULUS FILTRATION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOASSAY; IMMUNOFLUORESCENCE; IN VIVO STUDY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEINURIA; RAT; SHAM PROCEDURE; SPRAGUE DAWLEY RAT; URINARY EXCRETION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; IMMUNOASSAY; KIDNEY GLOMERULUS; MALE; MEMBRANE PROTEINS; OLIGOPEPTIDES; PIPERIDINES; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A;

EID: 79953828524     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-2021-4     Document Type: Article

References (43)

1. Held PJ, Brunner F, Odaka M, Garcia JR, Port FK, Gaylin DS (1990) Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis 15:451-457 (Pubitemid 20174015)
2. Breyer JA, Bain RP, Evans JK et al (1996) Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int 50:1651-1658 (Pubitemid 26364271)
3. Badr KF, Munger KA, Sugiura M, Snajdar RM, Schwartzberg M, Inagami T (1989) High and low affinity binding sites for endothelin on cultured rat glomerular mesangial cells. Biochem Biophys Res Commun 161:776-781 (Pubitemid 19162702)
4. Rebibou JM, He CJ, Delarue F et al (1992) Functional endothelin 1 receptors on human glomerular podocytes and mesangial cells. Nephrol Dial Transplant 7:288-292
5. Tomita K, Nonoguchi H, Marumo F (1992) Regulation of NaCl transport by endothelin in renal tubules. Semin Nephrol 12:30-36
6. Firth JD, Ratcliffe PJ, Raine AE, Ledingham JG (1988) Endothelin: an important factor in acute renal failure? Lancet 2:1179-1182
7. Ruiz-Ortega M, Gomez-Garre D, Alcazar R et al (1994) Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis. J Hypertens Suppl 12:S51-S58 (Pubitemid 24247678)
8. Hocher B, Lun A, Priem F, Neumayer HH, Raschack M (1998) Renal endothelin system in diabetes: comparison of angiotensin-converting enzyme inhibition and endothelin-A antagonism. J Cardiovasc Pharmacol 31(Suppl 1):S492-S495 (Pubitemid 128709991)
9. Fukui M, Nakamura T, Ebihara I et al (1993) Gene expression for endothelins and their receptors in glomeruli of diabetic rats. J Lab Clin Med 122:149-156 (Pubitemid 23239145)
10. Khan MA, Dashwood MR, Mumtaz FH, Thompson CS, Mikhailidis DP, Morgan RJ (1999) Upregulation of endothelin A receptor sites in the rabbit diabetic kidney: potential relevance to the early pathogenesis of diabetic nephropathy. Nephron 83:261-267 (Pubitemid 29486405)
11. Shin SJ, Hsiao PJ, Hsieh MC, Lee YJ, Tsai JH (1999) Increased urinary endothelin-1 excretion in newly diagnosed type 2 diabetic patients. Kaohsiung J Med Sci 15:589-596
12. Sasser JM, Sullivan JC, Hobbs JL et al (2007) Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. J Am Soc Nephrol 18:143-154 (Pubitemid 46053429)
13. Gagliardini E, Corna D, Zoja C et al (2009) Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes. Am J Physiol Renal Physiol 297:F1448-F1456
14. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Rollin BJ, Tesch GH (2006) Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 69:73-80 (Pubitemid 43117741)
15. Sugimoto H, Shikata K, Hirata K et al (1997) Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes 46:2075-2081 (Pubitemid 27512099)
16. Viberti GC, Messent J (1991) Risk factors for renal and cardiovascular disease in diabetic patients. Cardiology 79(Suppl 1): 55-61
17. Langham RG, Kelly DJ, Cox AJ et al (2002) Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia 45:1572-1576
18. Baelde HJ, Eikmans M, Doran PP, Lappin DW, de Heer E, Bruijn JA (2004) Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis 43:636-650 (Pubitemid 38401879)
19. Opgenorth TJ, Adler AL, Calzadilla SV et al (1996) Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist. J Pharmacol Exp Ther 276:473-481 (Pubitemid 126660483)
20. Misra RP (1972) Isolation of glomeruli from mammalian kidneys by graded sieving. Am J Clin Pathol 58:135-139
21. Savin VJ, Sharma R, Lovell HB, Welling DJ (1992) Measurement of albumin reflection coefficient with isolated rat glomeruli. J Am Soc Nephrol 3:1260-1269
22. Wenzel RR, Littke T, Kuranoff S et al (2009) Avosentan reduces albumin excretion in diabetics with macroalbuminuria. J Am Soc Nephrol 20:655-664
23. Opocensky M, Kramer HJ, Backer A et al (2006) Late-onset endothelin-A receptor blockade reduces podocyte injury in homozygous Ren-2 rats despite severe hypertension. Hypertension 48:965-971 (Pubitemid 44612710)
24. Hocher B, Schwarz A, Reinbacher D et al (2001) Effects of endothelin receptor antagonists on the progression of diabetic nephropathy. Nephron 87:161-169 (Pubitemid 32215829)
25. Morigi M, Buelli S, Zanchi C et al (2006) Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling. Am J Pathol 169:1965-1975 (Pubitemid 351181958)
26. Harita Y, Kurihara H, Kosako H et al (2009) Phosphorylation of nephrin triggers Ca2+ signaling by recruitment and activation of phospholipase C-γ1. J Biol Chem 284:8951-8962
27. Saleh MA, Boesen EI, Pollock JS, Savin VJ, Pollock DM (2010) Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat. Hypertension 56:942-949
28. Bonnet F, Cooper ME, Kawachi H, Allen TJ, Boner G, Cao Z (2001) Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia 44:874-877 (Pubitemid 32642460)
29. Collino F, Bussolati B, Gerbaudo E et al (2008) Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol 294:F1185-F1194
30. Shikata K, Makino H (2001) Role of macrophages in the pathogenesis of diabetic nephropathy. Contrib Nephrol 134:46-54
31. Luft FC, Mervaala E, Muller DN et al (1999) Hypertension-induced end-organ damage: a new transgenic approach to an old problem. Hypertension 33:212-218 (Pubitemid 29065662)
32. Rothlein R, Wegner C (1992) Role of intercellular adhesion molecule-1 in the inflammatory response. Kidney Int 41:617-619
33. Galkina E, Ley K (2006) Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol 17:368-377
34. Hirata K, Shikata K, Matsuda M et al (1998) Increased expression of selectins in kidneys of patients with diabetic nephropathy. Diabetologia 41:185-192 (Pubitemid 28088395)
35. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Tesch GH (2005) Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol 16:1711-1722 (Pubitemid 41716477)
36. Luster AD (1998) Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338:436-445
37. Wada T, Furuichi K, Sakai N et al (2000) Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 58:1492-1499
38. Rovin BH, Tan LC (1993) LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int 43:218-225 (Pubitemid 23167469)
39. Ihm CG, Park JK, Hong SP et al (1998) A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells. Nephron 79:33-37
40. Schena FP, Gesualdo L, Grandaliano G, Montinaro V (1997) Progression of renal damage in human glomerulonephritides: is there sleight of hand in winning the game? Kidney Int 52:1439-1457
41. Kanamori H, Matsubara T, Mima A et al (2007) Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy. Biochem Biophys Res Commun 360:772-777 (Pubitemid 47077388)
42. Hayasaki Y, Nakajima M, Kitano Y, Iwasaki T, Shimamura T, Iwaki K (1996) ICAM-1 expression on cardiac myocytes and aortic endothelial cells via their specific endothelin receptor subtype. Biochem Biophys Res Commun 229:817-824 (Pubitemid 27035801)
43. Chen P, Shibata M, Zidovetzki R, Fisher M, Zlokovic BV, Hofman FM (2001) Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures. J Neuroimmunol 116:62-73 (Pubitemid 32322640)